Table 2.
Distribution of vitamin D levels for each group.
| All vitamin D assays | Nodule (n = 42) | Remission (n = 45) | Active (n = 24) | |
|---|---|---|---|---|
| Vitamin D group | Count (%) | Count (%) | Count (%) | P- value |
| <25 nmol/L | 1 (2) | 2 (4) | 0 | |
| 25–75 nmol/L | 22 (52) | 18 (40) | 11 (46) | |
| >75 nmol/L | 19 (45) | 25 (56) | 13 (54) | .74 |
|
| ||||
| Vitamin D group | ||||
| <75 nmol/L | 22 (52) | 20 (44) | 10 (42) | |
| ≥75 nmol/L | 20 (48) | 25 (56) | 14 (58) | .67 |
|
| ||||
| Tandem mass spec assay | Nodule (n = 33) | Remission (n = 35) | Active (n = 22) | |
|
| ||||
| Vitamin D group | Count (%) | Count (%) | Count (%) | P- value |
| <25 nmol/L | 0 | 1 (3) | 0 | |
| 25–75 nmol/L | 17 (52) | 14 (40) | 9 (41) | |
| >75 nmol/L | 16 (48) | 20 (57) | 13 (59) | .75 |
|
| ||||
| Vitamin D group | ||||
| <75 nmol/L | 16 (48) | 15 (43) | 8 (36) | |
| ≥75 nmol/L | 17 (52) | 20 (57) | 14 (64) | .32 |